• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » February 200 – The CenterWatch Monthly : Volume 7, Issue 2, February 2000
February 200 – The CenterWatch Monthly : Volume 7, Issue 2, February 2000

February 200 – The CenterWatch Monthly : Volume 7, Issue 2, February 2000

$79.00

Product Details

Surfing for Study Subjects

Although service providers have long offered Internet-based patient recruitment solutions; large health portals are eyeing the clinical trials industry as an important revenue source.

The January merger of an SMO--Affiliated Research Centers--and AmericasDoctor.com may facilitate other SMO, and even CRO, alliances with major health portals.

EMR: Gearing Up for Prime Time

Current use of electronic medical records is very low, but pending HIPAA requirements will likely accelerate adoption rates.EMRs are expected to play a dramatic role in reducing development cycle times and costs; the question is, when will they begin to do so?

CentreStage Europe: Russian Market Meets its First SMO

Despite some ongoing problems, the Russian market is becoming a more attractive location in which to conduct clinical trials due to high levels of investigator motivation and a treatment-naive patient population. Geny, a Boston-based SMO, was founded specifically to navigate the problems still to be encountered in Russia when conducting trials.

Eye On: Prostate Cancer

CenterWatch editorial has identified 52 therapies in the clinical research pipeline for the treatment of the most common cancer diagnosed in men--prostate cancer. Primary areas of research include gene therapy, immunologic agents, vaccines, anti-angiogenesis and drug delivery.

  • Month in Review
  • Opportunities Underway
  • TrialWatch
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing